BLOOD PRESSURE CONTROL IN PATIENTS WITH NEWLY DIAGNOSED TYPE 2 DIABETES MELLITUS
Main Article Content
Abstract
Introduction: Type 2 diabetes mellitus (T2DM) is a common cardiovascular risk factor in Vietnam. Newly diagnosed T2DM patients require aggressive multifactorial cardiovascular risk management, including blood pressure control, to reduce complications and mortality. Objective: This study aims to determine the rate of blood pressure control among newly diagnosed T2DM patients. Methods: A descriptive cross-sectional study was conducted on newly diagnosed T2DM patients within 6 months at the Endocrinology and Family Medicine Clinics of Ho Chi Minh City University Medical Center. Results: A total of 275 newly diagnosed T2DM patients participated in the study. The comorbidity rate of hypertension was 32.7%, with 27.8% achieving target blood pressure. Based on clinic blood pressure readings, 56.4% had blood pressure > 130/80 mmHg. Factors associated with not achieving target clinic blood pressure included age < 60 (OR 0.4, 95% CI 0.2-0.8), overweight/obesity (OR 2.1, 95% CI 1.1-3.8) and use of ACEi/ARB (OR 3.2, 95% CI 1.4-7.0). Conclusions: Newly diagnosed T2DM patients with comorbid hypertension as well as rates of uncontrolled office blood pressure require careful attention. Those who are overweight/obese or ACEi/ARB monotherapy should be followed closely to achieve target blood pressure in the clinic.
Article Details
Keywords
Newly diagnosed type 2 diabetes mellitus, office blood pressure, blood pressure control
References
2. Kintscher U. Benefit of Blood Pressure Control in Diabetic Patients. Curr Hypertens Rep. 2015 Jul;17(7):50. doi: 10.1007/s11906-015-0561-1.
3. Van Minh H, Van Huy T, Long DPP, et al. Highlights of the 2022 Vietnamese Society of Hypertension guidelines for the diagnosis and treatment of arterial hypertension: The collaboration of the Vietnamese Society of Hypertension (VSH) task force with the contribution of the Vietnam National Heart Association (VNHA): The collaboration of the Vietnamese Society of Hypertension (VSH) task force with the contribution of the Vietnam National Heart Association (VNHA). J Clin Hypertens (Greenwich). 2022 Sep;24(9):1121-1138. doi: 10.1111/jch.14580.
4. Muddu M, Mutebi E, Ssinabulya I, et al. Hypertension among newly diagnosed diabetic patients at Mulago National Referral Hospital in Uganda: a cross sectional study. Cardiovasc J Afr. 2018 Jul/Aug 23;29(4): 218-224. doi: 10.5830/ CVJA-2018-015.
5. Bộ Y tế. Hướng dẫn chẩn đoán và điều trị đái tháo đường típ 2 (Ban hành kèm theo Quyết định số 5481/QĐ-BYT ngày 30 tháng 12 năm 2020). https://daithaoduong.kcb.vn/huong-dan-chan-doan-va-dieu-tri-dai-thao-duong-tip-2
6. Aggarwal R, Chiu N, Wadhera RK, et al. Racial/Ethnic Disparities in Hypertension Prevalence, Awareness, Treatment, and Control in the United States, 2013 to 2018. Hypertension. 2021 Dec;78(6):1719-1726. doi: 10.1161/ HYPERTENSIONAHA.121.17570.
7. Raghavan S, Ho YL, Kini V, et al. Association Between Early Hypertension Control and Cardiovascular Disease Incidence in Veterans With Diabetes. Diabetes Care. 2019 Oct; 42(10):1995-2003. doi: 10.2337/dc19-0686.
8. Kramer CK, Leitão CB, Canani LH, et al. Impact of white-coat hypertension on microvascular complications in type 2 diabetes. Diabetes Care. 2008 Dec;31(12):2233-7. doi: 10.2337/ dc08-1299.
9. Unger T, Borghi C, Charchar F, et al. 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension. 2020 Jun;75(6):1334-1357. doi: 10.1161/ HYPERTENSIONAHA.120.15026.
10. Adnan M, Noor W, Baig MMA. Risk factors of previously undiagnosed and known untreated hypertension among patients with Type-2 diabetes mellitus. Pak J Med Sci. 2023 Mar-Apr; 39(2): 361-366. doi: 10.12669/pjms. 39.2.6329.